Evolent Health, Inc.

NYSE:EVH

Medical - Healthcare Information Services

Healthcare
$3.93 -6.00%

-$0.28 today

Market cap
$442.05M
Beta
0.83
P/E (TTM)
-1.0
EPS (TTM)
-$4.44
52W Low $2.10High $12.07

Volume 3.10M

Average 2.78M

EVH Operating Income

Profit from core operations after operating expenses, before interest and taxes.

Evolent Health, Inc.NYSE: EVH

Operating Income · Q1 FY2026 · quarter ended Mar 2026

Operating income remains negative

Q1 FY2026 operating income was -$10.14M, compared with -$1.62M a year earlier. Trailing-twelve-month operating income was -$16.29M.

Context

  • Operating income amounted to 0.2% of revenue in FY2025, down 1.3 pp from a year earlier.
  • Operating income increased in 2 of the last 3 fiscal years.

What to watch

Whether operating income reaches the consensus estimate from 10 analysts of $79.67M (+1896.3%) for the fiscal year ending Dec 2026, a step up from the +89.0% reported in FY2025.

Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.

Latest quarterMar 2026
-$10.14M-5.2% QoQ
Last fiscal yearDec 2025
-$4.44M+89.0% YoY
LTMMar 2026
-$16.29M+43.2% YoY
Operating Income past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-525.0%+454.9%+979.9 pp
1 year+89.0%+1896.3%+1807.3 pp
3-year CAGR———
5-year CAGR——
10-year CAGR——

Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.

Operating Income history

USD · from the income statement

Latest · FY2025
(4.44M) USD
Year-over-year change
+89.0%
Reported Analyst consensus estimate Further estimates hidden. Sign in to unlock

Operating Income vs competitors

How EVH compares with its peers on the latest reported figures

  • EVH's LTM Mar 2026 operating income of -$16.29M is the 4th highest of the 11 companies compared; the peer median is -$103.86M.
  • Its year-over-year change of +43.2% is the 2nd highest of 11, against a peer median of -13.8%.
  • Operating income amounts to 0.9% of revenue for EVH, versus a peer median of 62.7%.
EVH Competitors Peer median
Operating Income for EVH and competitors
Company Period LTM YoY 3-year CAGR% of revenue
NUTXNutex Health, Inc.LTM Mar 2026$276.23M +37.2%—31.4%
HSTMHealthStream, Inc.LTM Mar 2026$23.37M +17.0%+17.6%7.5%
AMNAMN Healthcare Services, Inc.LTM Mar 2026$10.05M +107.7%-62.9%0.3%
EVHEvolent Health, Inc.LTM Mar 2026-$16.29M +43.2%—0.9%
BFLYButterfly Network, Inc.LTM Mar 2026-$81.44M -15.9%—79.1%
PSNLPersonalis, Inc.LTM Mar 2026-$102.52M -52.8%—158.9%
MGTXMeiraGTx Holdings plcLTM Mar 2026-$105.19M +33.9%—131.9%
AVBPArriVent BioPharma, Inc. Common StockLTM Mar 2026-$156.87M -11.7%——
KURAKura Oncology, Inc.LTM Mar 2026-$317.75M -56.2%—443.5%
REPLReplimune Group, Inc.LTM Dec 2025-$326.46M -35.4%——
MYGNMyriad Genetics, Inc.LTM Mar 2026-$383.5M -208.0%—46.3%
Peer median (excluding EVH) -$103.86M-13.8%-22.6%62.7%

Competitors are the stored peer set for EVH. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue907.96M1.35B1.96B2.55B1.88B
Cost of Revenue657.55M1.04B1.5B2.19B1.59B
Gross Profit250.41M316.58M460.47M367.35M284.03M
Gross Margin27.6%23.4%23.4%14.4%15.1%
Research & Development027M000
Selling, General & Admin219.5M269.27M358.11M263.05M288.47M
Operating Expenses292.82M312.94M531.68M407.84M288.47M
Depreciation & Amortization60.04M90.25M123.42M123.17M115.85M
EBITDA55.66M43.75M(24.79M)84.85M(361.31M)
EBITDA Margin6.1%3.2%-1.3%3.3%-19.3%
Operating Income(42.41M)3.64M(71.21M)(40.49M)(4.44M)
Operating Margin-4.7%0.3%-3.6%-1.6%-0.2%
Interest Income407K1.37M5.26M5.54M4.19M
Interest Expense25.43M15.57M54.21M24.72M57.47M
Other Income / Expenses12.61M(65.72M)(131.19M)(22.55M)(530.2M)
Income Before Tax(29.8M)(62.08M)(202.41M)(63.04M)(534.64M)
Pre-Tax Margin-3.3%-4.6%-10.3%-2.5%-28.5%
Income Tax Expense483K(43.38M)(89.37M)(1.41M)(126K)
Net Income(37.6M)(19.16M)(113.04M)(61.62M)(534.51M)
Net Margin-4.1%-1.4%-5.8%-2.4%-28.5%
EPS (Basic)(0.36)(0.20)(1.28)(0.81)(5.07)
EPS (Diluted)(0.36)(0.20)(1.28)(0.81)(5.07)
Weighted Avg Shares86.07M93.7M111.25M114.68M114.21M
Weighted Avg Shares (Diluted)86.07M93.7M111.25M114.68M114.21M

Evolent Health, Inc.

NYSE:EVH

Intrinsic Alpha fair value

Locked

Current Price

$3.93

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.